CEN Exam Requirements: Who Qualifies and How to Apply

Septic arthritis is an orthopedic emergency characterized by bacterial invasion of the joint space, resulting in rapid cartilage destruction. A synovial fluid leukocyte count of 55,000/mcL, typically with more than 75% to 90% polymorphonuclear neutrophils, strongly indicates acute septic arthritis, as non-infectious inflammatory joint effusions rarely exceed 50,000 white blood cells per microliter. A synovial fluid red cell count exceeding 100,000/mcL denotes hemarthrosis, which commonly occurs secondary to intra-articular fractures, ligamentous tears, or bleeding diatheses rather than primary bacterial joint infection. The presence of rhomboid-shaped birefringent crystals is the hallmark of pseudogout (calcium pyrophosphate dihydrate deposition disease), an inflammatory crystal arthropathy rather than a septic process. A synovial fluid glucose concentration of 95 mg/dL reflects a normal or near-serum value, whereas septic arthritis classically causes marked synovial hypoglycemia with fluid glucose levels falling significantly below 50% of the simultaneous serum glucose concentration due to leukocyte and bacterial consumption.

Acute compartment syndrome occurs when elevated osteofascial compartment pressure compromises capillary perfusion, leading to progressive tissue ischemia. Severe pain during passive muscle stretch of the ischemic compartment muscles is the earliest and most sensitive clinical finding, as ischemic muscle fibers are exquisitely sensitive to elongation. Pain out of proportion to the underlying injury is another prominent early sign. In contrast, absence of palpable distal pedal pulses is a very late and ominous finding indicating severe arterial compromise, often signaling irreversible tissue necrosis. Loss of two-point sensory discrimination reflects progressive sensory nerve ischemia; while paresthesias and sensory deficits precede motor paralysis, passive stretch pain remains the earliest sensitive bedside finding. Pitting edema and coolness of the toes signify localized venous congestion, soft tissue swelling, or severe vascular insufficiency, but they lack sensitivity and specificity for early elevated intracompartmental pressures.

Federal regulatory standards established by the Centers for Medicare and Medicaid Services (CMS) and The Joint Commission mandate specific time limits for violent or self-destructive restraint orders based on patient age. For pediatric patients aged 9 to 17 years, violent restraint orders are strictly limited to a maximum duration of 2 hours. A time limit of 1 hour is the regulatory maximum for pediatric patients under 9 years of age. A time limit of 4 hours applies only to adult patients aged 18 years and older. A time limit of 8 hours is noncompliant with emergency behavioral restraint regulations across all patient demographics, as no single violent restraint order may exceed 4 hours without reassessment and reauthorization. Nurses must continually assess safety, neurovascular integrity, skin condition, and readiness for restraint removal, ensuring the physician or licensed independent practitioner re-evaluates the patient before or at the expiration of the 2-hour window.

Cryoprecipitate is the primary reversal agent indicated for acute, life-threatening bleeding or symptomatic intracranial hemorrhage occurring secondary to intravenous alteplase therapy. Alteplase, a recombinant tissue plasminogen activator, induces systemic fibrinolysis, resulting in severe fibrinogen depletion and circulating fibrin degradation products. Administering cryoprecipitate rapidly replenishes fibrinogen (factor I) and factor VIII, restoring hemostatic capacity and halting fibrinolytic bleeding; current guidelines recommend maintaining a fibrinogen level greater than 150 to 200 mg/dL. Vitamin K is the specific reversal agent for warfarin-associated coagulopathy by promoting the hepatic synthesis of vitamin K-dependent clotting factors, but it has no therapeutic utility against thrombolytic-induced fibrinogenolysis. Protamine sulfate is the specific reversal agent for unfractionated heparin and partial reversal for low-molecular-weight heparin, neutralizing heparin molecules via electrostatic binding rather than restoring depleted clotting substrates. Idarucizumab is a monoclonal antibody fragment specifically designed to rapidly bind and reverse the direct thrombin inhibitor dabigatran, offering no mechanism to counteract tissue plasminogen activators.

Benzodiazepines are the first-line pharmacologic agents for managing psychomotor agitation and preventing withdrawal seizures and delirium tremens in patients experiencing alcohol withdrawal. Ethanol enhances gamma-aminobutyric acid (GABA) receptor inhibitory action while inhibiting N-methyl-D-aspartate (NMDA) neuroexcitation. Chronic alcohol exposure downregulates GABA-A receptors and upregulates NMDA receptors, so abrupt cessation leaves central nervous system excitation unopposed; benzodiazepines, positive allosteric modulators of the GABA-A receptor, restore neuronal inhibition. Antipsychotics lower the seizure threshold and can exacerbate hyperthermia, cardiac dysrhythmias, and extrapyramidal symptoms, making them unsafe as monotherapy. Beta-blockers can mitigate autonomic hyperactivity such as tachycardia and tremor, but they do not prevent seizures or delirium tremens and can mask key warning signs of progressive withdrawal. Anticonvulsants, although sometimes evaluated as adjunctive therapy in mild withdrawal, lack robust evidence for preventing delirium tremens and status epilepticus compared to benzodiazepine protocols. Prompt symptom-triggered benzodiazepine administration remains the evidence-based standard of care in the emergency department setting.